These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3137685)

  • 41. Pharmacokinetics in chimpanzees of recombinant human tissue-type plasminogen activator produced in mouse C127 and Chinese hamster ovary cells.
    Tanigawara Y; Hori R; Okumura K; Tsuji J; Shimizu N; Noma S; Suzuki J; Livingston DJ; Richards SM; Keyes LD
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):517-22. PubMed ID: 2110870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers.
    Seifried E; Tanswell P; Rijken DC; Barrett-Bergshoeff MM; Su CA; Kluft C
    Arzneimittelforschung; 1988 Mar; 38(3):418-22. PubMed ID: 3132929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.
    Schneider J; Friderichs E; Günzler WA; Flohé L
    Thromb Res; 1989 Oct; 56(1):59-65. PubMed ID: 2512686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.
    Dodd I; Nunn B; Robinson JH
    Thromb Haemost; 1988 Jun; 59(3):523-8. PubMed ID: 3142086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
    Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
    Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
    Einarsson M; Hggroth L; Mattsson C
    Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
    Garabedian HD; Gold HK; Leinbach RC; Johns JA; Yasuda T; Kanke M; Collen D
    J Am Coll Cardiol; 1987 Mar; 9(3):599-607. PubMed ID: 3102584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.
    Lim JI; Maguire AM; John G; Mohler MA; Fiscella RG
    Ophthalmology; 1993 Mar; 100(3):373-6. PubMed ID: 8460008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo.
    Knabb RM; Chiu AT; Reilly TM
    Thromb Res; 1990 Jul; 59(2):309-17. PubMed ID: 2122539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of tissue plasminogen activator in an isolated extracorporeal circuit.
    Geier B; Grossefeld M; Barbera L; Mumme A
    J Vasc Surg; 2001 Jan; 33(1):165-9. PubMed ID: 11137937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers.
    Kemme MJ; Burggraaf J; Schoemaker RC; Cohen AF
    Thromb Res; 2001 Jul; 103(1):9-16. PubMed ID: 11434941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraocular penetration of topical tissue plasminogen activator.
    Lim JI; Fiscella R; Tessler H; Gagliano DA; Chaques-Alepuz V; Mohler MA
    Arch Ophthalmol; 1991 May; 109(5):714-7. PubMed ID: 1902662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
    J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal clearance of tissue plasminogen activator in the rabbit.
    Jaffe GJ; Green GD; McKay BS; Hartz A; Williams GA
    Arch Ophthalmol; 1988 Jul; 106(7):969-72. PubMed ID: 3134000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.
    Haley EC; Brott TG; Sheppard GL; Barsan W; Broderick J; Marler JR; Kongable GL; Spilker J; Massey S; Hansen CA
    Stroke; 1993 Jul; 24(7):1000-4. PubMed ID: 8322373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination, pharmacokinetics and protein binding of a novel tissue-type plasminogen activator, pamiteplase in human plasma.
    Oikawa K; Watanabe T; Miyamoto I; Higuchi S
    Xenobiotica; 2000 Oct; 30(10):993-1003. PubMed ID: 11315107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.